Role of bisphosphonates in the management of acute Charcot foot

doi:10.4239/wjd.v9.i7.115

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8915)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

705

WORD

261

HTML

5795

Figures (1-2)

243

Tables (1-1)

185

Sum=7189

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

917

Download

809

Sum=1726

Jul 15, 2018 (publication date) through Jul 6, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jul 15, 2018; 9(7): 115-126
Published online Jul 15, 2018. doi: 10.4239/wjd.v9.i7.115

Full Size Figure Download Figure

Figure 2 Molecular mechanisms of bisphosphonates. NN-BP: Non-nitrogen containing bisphosphonates; N-BP: Nitrogen containing bisphosphonates; FPP: Farnesyl pyrophosphate; IPP: Isopentenyl diphosphonate; ApppI: Triphosphoric acid 1-adenosin-5’-yl ester 3-[3-methylbut-3-enyl]ester.

Citation: Durgia H, Sahoo J, Kamalanathan S, Palui R, Sridharan K, Raj H. Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes 2018; 9(7): 115-126
URL: https://www.wjgnet.com/1948-9358/full/v9/i7/115.htm
DOI: https://dx.doi.org/10.4239/wjd.v9.i7.115